Due to the legal and regulatory challenges in researching cannabinoids derived from the cannabis plant in the United States, Intiva BioPharma Inc. is initially focused on developing drugs utilizing synthetic cannabinoids . If the Company intends to proceed in researching pharmaceuticals derived from the … Read More
The post Kinder Holding Corp. Receives FINRA Approval For Name Change to Intiva Biopharma Inc., and … appeared first on Dagga Magazine.